From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

“I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary findings prove yet again that it’s time to bust up the PBM monopoly.” Eisai ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...

The Federal Trade Commission (FTC) announced on Tuesday that it will be taking action against the online cash app and neobank Dave, which it says used “misleading marketing to deceive consumers.” ...

November 07, 2024 - After more than 15 months of delay, significant proposed changes to the U.S.-antitrust review process seem headed for implementation as early as January 2025 with the Oct. 10 ...

FTC Modderfontein's Night Drill event on November 1 lived up to every bit of the hype. FTC Modderfontein’s Night Drill event on November 1 lived up to every bit of the hype. Flames reached over ...